Alaunos completes its acquisition of Velaris Therapeutics alongside an oversubscribed $350 million private placement, adding a pulmonary arterial hypertension pipeline led by VLR199. Investorideas.com (www.investorideas.com) a trusted platform for investing…
Tag:
